The weight-loss frenzy is making some pharma stocks much more volatile. Will the drama continue?
The latest volatility in key GLP-1 shares has put the highlight on the anxiousness Wall Road has in regards to the weight reduction market. The market is big — a possible $150 billion a 12 months by the tip of the last decade — and any monetary miss, or unfavorable knowledge of any variety, will … Read more